For the fourth quarter ended March 2018, Granules India showed a subdued revenue growth but margins looked steady. Profit was supported by income from the OmniChem joint venture.
C Krishna Prasad, MD, Granules India speaking about the quarter’s performance and the outlook going forward said for the full year FY18 they expect a minimum of 20 percent topline growth and bottomline in a proportionate way. The fair estimate for FY18 EPS would be Rs 9, he said. The FY17 EPS came in at Rs 7.48.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!